MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath , will hold a conference call to discuss its first quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Thursday, February 14, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Thursday, February 14.
www.cryocath.com
CryoCath - www.cryocath.com - is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.
This press release includes “forward-looking statements” that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath’s annual report available at www.sedar.com under the heading Risks and Uncertainties in the Management’s Discussion and Analysis section.
CONTACT: visit our website at www.cryocath.com, or contact: Michael Moore,
Investor Relations, Phone: (416) 815-0700 ext. 241, Fax: (416) 815-0080,
E-mail: mmoore@equicomgroup.com